Dr. James Lilja

CEO, CMO & Co-Founder

The Chief Executive Officer (CEO), among other important responsibilities, defines the organization's long-term and short-term objectives.
The Chief Medical Officer (CMO) oversees clinical operations and ensures the MMTT trial is performing effectively and efficiently.
James Lilja, MD<br>CEO, CMO

James has been working for 10 years managing clinical trials, and is author of the MMTT trial, and co-author of the HIPEC and total body hyperthermia treatment trial.

He has an abiding interest in expanding access for cancer patients to clinical trial treatments, and has catalyzed the creation of the Coshire infrastructure to do so.